CDC sexually transmitted diseases treatment guidelines

Clinical Infectious Diseases

Volumn 35, Issue SUPPL. 2, 2002, Pages

  Workowski, Kimberly A ^a   Berman, Stuart M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; OFLOXACIN;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; EDITORIAL; GENITAL HERPES; GONOCOCCAL URETHRITIS; GONORRHEA; HERPES SIMPLEX VIRUS 2; HUMAN; NEISSERIA GONORRHOEAE; PARASITOSIS; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCTITIS; PUBLIC HEALTH SERVICE; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; UTERINE CERVICITIS; VAGINITIS;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HUMANS; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 0037108382     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/342100     Document Type: Editorial

References (11)

1. Cates W, the American Social Health Association Panel. Estimates of the incidence and prevalence of STDs in the United States. Sex Transm Dis 1999; 26(Suppl 4):S2-7.
2. CDC. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1-80.
3. Magid D, Douglas JM, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med 1996; 124:389-99.
4. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-11.
5. Fleming DT, Wasserheit JN. From epidemiologic synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
6. Kahn RH, Heffelfinger JD, Berman SM. Syphilis outbreaks among men who have sex with men. A public health trend of concern. Sex Transm Dis 2002; 29:285-7.
7. Solomon D, Schiffman M, Tarone R. Comparison ofthree management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93:293-9.
8. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group (ALTS). Hyman papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000; 92:397-402.
9. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002; 287:2382-90.
10. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333:1732-6.
11. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994; 171:345-9.